Lægemidler, som primært elimineres ved metabolisering i leveren, særligt ved glucuronidering, kan potentielt hæmme metaboliseringen af zidovudin.
Medicinal products which are primarily eliminated by hepatic metabolism especially via glucuronidation may have the potential to inhibit metabolism of zidovudine.